Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    Selection Criteria for Participants

    The iCMLf seeks to improve the resources and knowledge of physicians treating patients with CML in emerging regions. The iCMLf will select up to 20 hematologists for the program whose attendance is expected to provide most benefit in this CML community. Candidates should have a special interest in CML management and be able to demonstrate their ability to apply and disseminate to colleagues knowledge gained from the program.


    Application Process

    We are pleased that the program will continue in 2020. Candidates applying will be accepted into the program according to the selection criteria. Once selected, applicants will be matched with the most appropriate host site according to location, timing, languages spoken and other individual needs.

    Applications for the 2020 program are now closed.

    Application form and further information for download here